In this video I tell the basics behind Parkinson's disease and the currently used classes of medications. I synthesize a new medication of the MAO-B Inhibitor class, with a different structure compared to medication in the same class, that has recently been developed. This new inhibitor, KDS2010, can reversibly bind to the receptor and is very selective, a combination not found in current known MAO-B inhibitors. It seems to be a lot more effective and is currently in long-term trials.
Don't conduct any chemical reactions without proper and professional safety analysis and risk management. Measures taken can be invisible, not filmed, not properly visible on camera or misjudged by the viewer due to setup or video construction. Always conduct own appropriate measures regardless of video setup.
